Lijović Lada, Pelajić Stipe, Hawchar Fatime, Minev Ivaylo, da Silva Beatriz Helena Cermaria Soares, Angelucci Alessandra, Ercole Ari, de Grooth Harm-Jan, Thoral Patrick, Radočaj Tomislav, Elbers Paul
Department of Intensive Care Medicine, Laboratory for Critical Care Computational Intelligence, Amsterdam Medical Data Science, Amsterdam Public Health, Amsterdam Cardiovascular Science, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands; Department of Anesthesiology, Intensive Care and Pain Management, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia.
Department of Anesthesiology, Intensive Care and Pain Management, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia.
J Crit Care. 2023 Jun;75:154276. doi: 10.1016/j.jcrc.2023.154276. Epub 2023 Feb 10.
Accurate and actionable diagnosis of Acute Kidney Injury (AKI) ahead of time is important to prevent or mitigate renal insufficiency. The purpose of this study was to evaluate the performance of Kinetic estimated Glomerular Filtration Rate (KeGFR) in timely predicting AKI in critically ill septic patients.
We conducted a retrospective analysis on septic ICU patients who developed AKI in AmsterdamUMCdb, the first freely available European ICU database. The reference standard for AKI was the Kidney Disease: Improving Global Outcomes (KDIGO) classification based on serum creatinine and urine output (UO). Prediction of AKI was based on stages defined by KeGFR and UO. Classifications were compared by length of ICU stay (LOS), need for renal replacement therapy and 28-day mortality. Predictive performance and time between prediction and diagnosis were calculated.
Of 2492 patients in the cohort, 1560 (62.0%) were diagnosed with AKI by KDIGO and 1706 (68.5%) by KeGFR criteria. Disease stages had agreement of kappa = 0.77, with KeGFR sensitivity 93.2%, specificity 73.0% and accuracy 85.7%. Median time to recognition of AKI Stage 1 was 13.2 h faster for KeGFR, and 7.5 h and 5.0 h for Stages 2 and 3. Outcomes revealed a slight difference in LOS and 28-day mortality for Stage 1.
Predictive performance of KeGFR combined with UO criteria for diagnosing AKI is excellent. Compared to KDIGO, deterioration of renal function was identified earlier, most prominently for lower stages of AKI. This may shift the actionable window for preventing and mitigating renal insufficiency.
提前对急性肾损伤(AKI)进行准确且可采取行动的诊断对于预防或减轻肾功能不全至关重要。本研究的目的是评估动态估计肾小球滤过率(KeGFR)在及时预测重症脓毒症患者AKI方面的性能。
我们对阿姆斯特丹大学医学中心数据库(第一个免费的欧洲重症监护病房数据库)中发生AKI的脓毒症重症监护病房患者进行了回顾性分析。AKI的参考标准是基于血清肌酐和尿量(UO)的《改善全球肾脏病预后组织(KDIGO)》分类。AKI的预测基于KeGFR和UO定义的阶段。通过重症监护病房住院时间(LOS)、肾脏替代治疗需求和28天死亡率对分类进行比较。计算预测性能以及预测与诊断之间的时间。
在该队列的2492例患者中,根据KDIGO标准有1560例(62.0%)被诊断为AKI,根据KeGFR标准有1706例(68.5%)。疾病阶段的kappa一致性为0.77,KeGFR的敏感性为93.2%,特异性为73.0%,准确性为85.7%。对于KeGFR,识别1期AKI的中位时间快13.2小时,对于2期和3期分别快7.5小时和5.0小时。结果显示1期在LOS和28天死亡率方面存在轻微差异。
KeGFR联合UO标准诊断AKI的预测性能极佳。与KDIGO相比,肾功能恶化被更早识别,在AKI较低阶段最为显著。这可能会改变预防和减轻肾功能不全的可行动窗口。